This Gives You an “Automatic” 9.4% Return, in Cash, From Pfizer

Our Archive

Search completed

There’s a way for us dividend investors to tap the news of a COVID-19 vaccine for huge payouts of 10% and up. And we’ll position our portfolios for serious price upside, too.

I know the vaccine news has a bit of a “horse is out of the barn” feel to it. After all, the market and shares of the vaccine’s producer, Pfizer (PFE), have already popped (though the rally has taken a bit of a breather lately). But you’re not too late. With the three investments I’ll show you below, you could grab healthcare dividends much bigger than the 3.9% Pfizer pays now.… Read more

Read More

Finally—a selloff! It’s the perfect time for us to add secure monthly dividend stocks to our portfolio now that their valuations have landed back here on Planet Earth. I’m talking about every-30-day payers with dividends that annualize up to 7.1%.

Their price decline has increased their dividend yields, giving us a shot at a terrific combo: higher yields, monthly payouts and price upside. Yes, you read that right. We don’t have to “settle” for 7.1% yields that are paid to us monthly. By buying right, we can capture some price gains, to boot.

Monthly Dividend Stocks Make Sense for Retirees—and Aspiring Retirees

If you’re relying on your portfolio for income, monthly dividends are a godsend, because managing your cash flow from stocks paying quarterly is a total headache.… Read more

Read More

“It’s my money, and I want it now!”

That’s the rallying cry of everyday folks in commercials for J.G. Wentworth, a financial services firm that offers lump-sum cash payments for structured settlements, annuities, lottery payments and more. (If you’ve never seen one of these TV spots, I suggest you try one out. They’re so bad they’re good.)

Every income investor could (and probably should) take a cue from its motto. To quote another spot: “Show us the money!”

Monthly dividend stocks, of course, pay more often than any other income investment. Dividend checks coming in every 30 days are especially handy for retirees who have bills to pay.… Read more

Read More

If you’re like pretty well everyone else, you’re closely watching Gilead Sciences (GILD), creator of remdesivir, a drug that, last week, showed progress in treating the coronavirus in a US government study.

But does that make Gilead a good stock to buy now, particularly if you’re focused on income? Let’s take a look.

First up, unlike many other stocks these days, Gilead boasts a safe payout, with the dividend accounting for just 38% of free cash flow in the last 12 months. And the company has increased its dividend every year since initiating it in 2015:

A Reliable Dividend

It’s on the current-yield front where the dividend story starts to fray.… Read more

Read More

If you’re like pretty well everyone else, you’re closely watching Gilead Sciences (GILD), creator of remdesivir, a drug that, last week, showed progress in treating the coronavirus in a US government study.

But does that make Gilead a good stock to buy now, particularly if you’re focused on income? Let’s take a look.

First up, unlike many other stocks these days, Gilead boasts a safe payout, with the dividend accounting for just 38% of free cash flow in the last 12 months. And the company has increased its dividend every year since initiating it in 2015:

A Reliable Dividend

It’s on the current-yield front where the dividend story starts to fray.… Read more

Read More

The “race to zero” heats up again. You’ve surely heard that Vanguard is now slicing and dicing its already-low fees and commissions. That sounds great, but in reality, the low-fee race is pennywise yet dividend-foolish for us income investors.

To retire on secure, high-yielding long-term investments, we actually prefer to pay a fair management fee. I’ll outline this in a moment via a trio of secure 7% payers. Their generous yields tower above mainstream low-fee options:

More on these three dividend funds in a minute. First, let’s review why we prefer to pay for professional management.

Vanguard kicked off the new trading year by joining the “no-commission” fray that caught the likes of Charles Schwab (SCHW) and E*Trade (ETFC) by surprise in 2019.… Read more

Read More

If you ever want to retire (or stay retired!), you’ve got a big problem. Bonds don’t pay much now, and they’re likely to pay less and less in the months and years ahead.

I probably don’t have to tell you that the yield on the 10-year Treasury note has crashed to 1.6%. In other words, a $500K investment would get you a pathetic $4,000 in interest income every six months (as Treasuries only pay semiannually, unlike the three strong monthly dividend payers I’ll show you shortly).

Then there’s the specter of negative interest rates, something folks in many countries already know: today, $15 trillion of government bonds around the world are sloshing around with yields below zero.… Read more

Read More

Don’t become complacent with your dividends! Your portfolio and your income are at the whim of Fed Chair Jerome Powell—now more than ever.

I realize he’s acting like a “good boy” at the moment. But what if JP decides to go rogue again and exercise his independence? A surprise rate hike would be catastrophic to many income portfolios.

That means you need to “Fed-proof” your nest egg and your dividends. Today we’ll discuss four funds paying dividends up to 10.7% that do just that.

These four closed-end funds (CEFs) have been left for dead in this market rally. That makes them great “Fed insurance”: they’re cheap, so they’ve got built-in upside if the rally goes into overtime.… Read more

Read More

Don’t become complacent with your dividends! Your portfolio and your income are at the whim of Fed Chair Jerome Powell—now more than ever.

I realize he’s acting like a “good boy” at the moment. But what if JP decides to go rogue again and exercise his independence? A surprise rate hike would be catastrophic to many income portfolios.

That means you need to “Fed-proof” your nest egg and your dividends. Today we’ll discuss four funds paying dividends up to 10.7% that do just that.

These four closed-end funds (CEFs) have been left for dead in this market rally. That makes them great “Fed insurance”: they’re cheap, so they’ve got built-in upside if the rally goes into overtime.… Read more

Read More

Don’t become complacent with your dividends! Your portfolio and your income are at the whim of Fed Chair Jerome Powell—now more than ever.

I realize he’s acting like a “good boy” at the moment. But what if JP decides to go rogue again and exercise his independence? A surprise rate hike would be catastrophic to many income portfolios.

That means you need to “Fed-proof” your nest egg and your dividends. Today we’ll discuss four funds paying dividends up to 10.7% that do just that.

These four closed-end funds (CEFs) have been left for dead in this market rally. That makes them great “Fed insurance”: they’re cheap, so they’ve got built-in upside if the rally goes into overtime.… Read more

Read More

Categories